Win up to $2M in non-dilutive R&D capital.

I've reviewed NSF SBIR pitches, been on a winning SBIR team, and worked in R&D inside industry. The same pattern keeps showing up.

The most expensive mistake: founders write to the wrong audience. A large share of any review panel expects, explicitly or implicitly, a standard of academic rigor. Absolutes (“the best,” “revolutionary”), marketing tone, unsupported claims, no acknowledged limits, no engagement with prior work — these all read as the absence of it.

To founders these patterns can look superficial — or invisible. They aren't. The Pitch is judged on the written submission alone: no meeting, no follow-up, no chance to defend.

How it reads usually decides whether the proposal advances.